CH367831A - Process for the production of new basic substituted azepine derivatives - Google Patents
Process for the production of new basic substituted azepine derivativesInfo
- Publication number
- CH367831A CH367831A CH6210558A CH6210558A CH367831A CH 367831 A CH367831 A CH 367831A CH 6210558 A CH6210558 A CH 6210558A CH 6210558 A CH6210558 A CH 6210558A CH 367831 A CH367831 A CH 367831A
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- methyl
- parts
- acid
- piperidyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 150000001538 azepines Chemical class 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title description 2
- 239000002253 acid Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 5
- LCGTWRLJTMHIQZ-UHFFFAOYSA-N 5H-dibenzo[b,f]azepine Chemical class C1=CC2=CC=CC=C2NC2=CC=CC=C21 LCGTWRLJTMHIQZ-UHFFFAOYSA-N 0.000 description 4
- ZSMRRZONCYIFNB-UHFFFAOYSA-N 6,11-dihydro-5h-benzo[b][1]benzazepine Chemical class C1CC2=CC=CC=C2NC2=CC=CC=C12 ZSMRRZONCYIFNB-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NISITZDNUGPQFO-UHFFFAOYSA-N 3-chloro-1-methylpiperidine Chemical compound CN1CCCC(Cl)C1 NISITZDNUGPQFO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- -1 N-substituted azepine Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229960003750 ethyl chloride Drugs 0.000 description 2
- 229940050176 methyl chloride Drugs 0.000 description 2
- 229940078552 o-xylene Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- XMVGLLJLAIYTFJ-UHFFFAOYSA-N 2-ethyl-6-(2-phenylethenyl)cyclohexa-2,4-dien-1-imine Chemical compound C(C)C=1C(C(C=CC1)C=CC1=CC=CC=C1)=N XMVGLLJLAIYTFJ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- MYGXGCCFTPKWIH-UHFFFAOYSA-N 4-chloro-1-methylpiperidine Chemical compound CN1CCC(Cl)CC1 MYGXGCCFTPKWIH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002005 ganglioplegic effect Effects 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid group Chemical group C(C=1C(C(=O)O)=CC=CC1)(=O)O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Description
Verfahren zur Herstellung von neuen basisch substituierten Azepinderivaten
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von neuen basisch substituierten Azepinderivaten mit wertvÏllen pharmakologischen Eigenschaften.
Es wurde gefunden, dass N-substituierte Azepin- derivate der Formel
EMI1.1
worin X die Athylen-oderVinylengruppe,-CH2-CH2 bzw.-CH=CH-, Y die direkte Bindung oder einen Alkylenrest mit 1-3 Kohlenstoffatomen, Z, und Z2 Wasserstoff, Halogenatome oder niedermolekulare Alkylreste, und Am einen N-Alkyl-pyrrolidyl-oder N-Alkyl-piperidylrest bedeuten, wertvolle pharmakologische Eigenschaften, insbesondere antiallergische und sedative Wirksamkeit, besitzen. Quaternäre Ammoniumsalze, die sich von den vorstehend definierten tertiären Basen ableiten, wirken als Ganglioplegica.
Das erfindungsgemässe Verfahren zur Herstellung der neuen Verbindungen der Formel I ist dadurch gekennzeichnet, dass man ein Azepinderivat der Formel
EMI1.2
das heisst ein gegebenenfalls substituiertes 5-Dibenzo (b, f) azepin oder 10, ll-Dihydro-5-dibenzo (b, f)azepin, welches im folgenden als gegebenenfalls substituiertes Iminostilben bzw. Iminodibenzyl bezeichnet wird, in Gegenwart eines säurebindenden Mittels mit einem reaktionsfähigen Ester eines basischen Alkohols der Formel HO-Y-Am III umsetzt.
Als säurebindende Mittel eignen sich insbesondere Natriumamid, Natriumhydrid, Lithiumamid, Kaliumamid, Natrium, Lithium oder Kalium. Als reaktionsfähige Ester von basischen Alkoholen der Formel III kommen insbesondere die Halogenide in Frage. Im einzelnen seien genannt : 1-Methyl-3-chlor-piperidin,
1-Methyl-4-chlor-piperidin,
1-Methyl-pyrrolidyl-(2)-methylchlorid,
1-Methyl-piperidyl- (2)-methylchlorid,
1-Methyl-piperidyl- (3)-methylchlorid,
1-Methyl-piperidyl- (4)-methylchlorid, , [l-Methyl-piperidyl-(2)]-äthylchlorid sowie die entsprechenden Bromide.
Geeignete Ausgangsstoffe der Formel II sind beispielsweise das Iminodibenzyl und das Imino stilben sowie Mono-und Disubstitutionsprodukte derselben, wie
3-Athyl-iminodibenzyl,
3-Athyl-iminostilben,
3, 7-Dimethyl-iminodibenzyl,
2, 8-Dimethyl-iminodibenzyl,
3, 7-Dichlor-iminodibenzyl und
3, 7-Dichlor-iminostilben.
Durch Anlagerung von Halogeniden oder Sulfaten aliphatischer oder araliphatischer Alkohole, z. B. von Methyljodid, Dimethylsulfat, Athylbromid, Athyljodid oder Benzylchlorid, entstehen aus den tertiären Aminen der Formel I in üblicher Weise monoquater näre Ammoniumverbindungen, wobei die im Rest Am befindliche tertiäre Aminogruppe reagiert.
Mit anorganischen oder organischen Säuren, wie Salzsäure, Bromwasserstoffsäure, Schwefelsäure, Phosphorsäure, Methansulfonsäure, Sithansulfon- saure, Äthandisulfonsäure, Essigsäure, Bernsteinsaure, Fumarsäure, Maleinsäure, Äpfelsäure, Weinsaure, Citronensäure, Benzoesäure und Phthalsäure bilden die tertiären Basen Salze, welche zum Teil wasserlöslich sind.
In den nachfolgenden Beispielen bedeuten Teile Gewichtsteile, diese verhalten sich zu Volumteilen wie g zu cm3. Die Temperaturen sind in Celsiusgraden angegeben.
Beispiel 1
19, 5 Teile Iminodibenzyl werden in 125 Volumteilen o-Xylol gelöst und mit 3, 9 Teilen fein pulverisiertem Natriumamid versetzt. Die entstandene Suspension wird unter Rühren und Einleiten von Stickstoff so lange auf 100 erhitzt, bis kein Ammoniak mehr entweicht. Darauf wird der Kolbeninhalt auf 50 gekühlt und bei dieser Temperatur eine Lösung von 13, 4 Teilen 1-Methyl-3-chlorpiperidin in 60 Volumteilen o-Xylol zugetropft. Dann wird die Suspension zwei Stunden bei 100 gerührt und anschliessend 14 Stunden unter Rückfluss gekocht. Die auf 0 gekühlte Reaktionsmischung wird tropfenweise mit Wasser versetzt und während 2 Stunden gut durchgerührt. Die beiden Phasen werden nun getrennt, und die organische Phase wird mit ln Salzsäure ausgezogen.
Der saure wässrige Extrakt wird alkalisch gestellt und ausgeäthert, der Äther abgedampft und das zurückbleibende Öl im Hochvakuum fraktioniert. Man erhält 5- [1'-Methyl-piperidyl- (3')]- iminodibenzyl vom Kp. 165-167 bei 0, 02 mm Druck.
In analoger Weise erhält man : 5- [1'-Methyl-piperidyl- (4)]-iminodibenzyl vom Kp. 002 151-1546 ; 5- [1'-Methyl-piperidyl- (3')-methyl]-iminodibenzyl vom Kp. o ol 157-160 ;
5-[ss-{1'-Methyl-piperidyl-(2')}-äthyl]-inino dibenzyl vom Kp. 0003 178-181 und 5- [1'-Methyl-pyrrolidyl- (2')-methyl]-iminodibenzyl vom Kp. o, ol 145-147 .
Beispiel 2
19, 5 Teile Iminodibenzyl werden in 100 Volumteilen Benzol gelöst. In die Lösung wird Stickstoff eingeleitet und 3, 9 Teile Natriumamid werden eingetragen. Der Kolbeninhalt wird nun auf 80 erhitzt, bis kein Ammoniak mehr entweicht, und anschlie ssend auf 45 gekühlt. In die entstandene Suspension wird eine Lösung von 14, 8 Teilen 1-Methyl-piperi- dyl- (2)-methylchlorid in 200 Volumteilen Benzol in anderthalb Stunden eingetropft.-Darauf wird die Reaktionsmischung 12 Stunden bei 45 gerührt und schliesslich noch zwei Stunden unter Rückfluss gekocht. Die rasch auf 5 gekühlte Mischung wird mit Wasser versetzt, zwei Stunden gerührt und die beiden Phasen werden getrennt. Der Benzolteil wird mit In Salzsäure ausgezogen.
Der saure wässrige Extrakt wird mit Natronlauge mimosaalkalisch gestellt und ausgeäthert. Nach dem Trocknen der ätherischen Lösung mit Kaliumcarbonat wird der Ather abgedampft und der Rückstand im Hochvakuum fraktioniert, wobei das 5- [1'-Methyl-piperidyl- (2')-methyl]-imino- dibenzyl unter 0, 02 mm Druck bei 165-167 über- geht. In analoger Weise erhält man das 5- [1'-Methyl piperidyl-(4R)-methyl]-iminodibenzyl vom Kp.0.02 172 bis 174 .
Beispiel 3
19, 3 Teile Iminostilben werden in 500 Volumteilen Benzol bei 50-60 gelöst. Zu dieser Lösung werden unter Einleiten von Stickstoff und Rühren nacheinander eine Lösung von 14, 8 Teilen N-Methylpiperidyl-4-methylchlorid in 400 Volumteilen Benzol und eine Aufschlämmung von 4, 0 Teilen Natriumamid in 12 Volumteilen Toluol zugetropft. Die erhaltene Suspension wird weitere 7 Stunden auf 45 erwärmt und dann 14 Stunden unter Rückfluss gekocht. Nach Kühlen mit Eis wird die Reaktionsmischung bei 0-5 mit 400 Teilen Wasser versetzt.
Die beiden Phasen werden getrennt und der alkalisch wässrige Teil gut mit Ather geschüttelt. Die Atherlösung wird mit der Benzolphase vereinigt und beide mit In Salzsäure ausgezogen. Der Salzsäureauszug wird hierauf mit Natronlauge alkalisch gestellt und ausgeäthert. Die Atherlösung wird mit Natriumcarbonat getrocknet und der Ather anschliessend abgedampft. Das zurückbleibende rohe öl wird im Hochvakuum destilliert, wobei man das 5- [1'-Methyl piperidyl- (4')-methyl]-iminostilben vom Kp. 176 bis 177 unter 0, 025 mm Druck erhält.
In analoger Weise erhält man das 5- [1'-Methyl piperidyl- (2')-methyl]-iminostilben vom Kp. 0,05 169 bis 172 .
Beispiel 4
19, 3 Teile Iminostilben werden bei 50-60 in 600 Volumteilen Xylol gelöst. Zu dieser Lösung tropft man 16, 2 Teile, cJ-[l-Methyl-piperidyl-(2)]- äthylchlorid, gelöst in 400 Volumteilen Xylol. Anschliessend gibt man zur Reaktionsmischung eine Aufschlämmung von 4, 0 Teilen Natriumamid in 12 Volumteilen Toluol, rührt das Ganze 7 Stunden bei 55 und kocht es schliesslich 14 Stunden unter Rückfluss. Dann kühlt man es mit Eis auf 0 und arbeitet analog den vorangehenden Beispielen auf, wobei man das 5- [ss-w 1'-Methyl-piperidyl-(2')}-äthyl]-iminostilben vom Kp. 170-172} unter 0, 004 mm Druck erhält.
Process for the production of new basic substituted azepine derivatives
The present invention relates to a process for the preparation of new basic substituted azepine derivatives with valuable pharmacological properties.
It has been found that N-substituted azepine derivatives of the formula
EMI1.1
where X is the ethylene or vinylene group, -CH2-CH2 or -CH = CH-, Y is the direct bond or an alkylene radical with 1-3 carbon atoms, Z, and Z2 is hydrogen, halogen atoms or low molecular weight alkyl radicals, and Am is an N-alkyl Pyrrolidyl or N-alkyl-piperidyl radicals have valuable pharmacological properties, in particular antiallergic and sedative activity. Quaternary ammonium salts derived from the tertiary bases defined above act as ganglioplegics.
The process according to the invention for preparing the new compounds of the formula I is characterized in that an azepine derivative of the formula
EMI1.2
that is, an optionally substituted 5-dibenzo (b, f) azepine or 10, ll-dihydro-5-dibenzo (b, f) azepine, which is hereinafter referred to as optionally substituted iminostilbene or iminodibenzyl, in the presence of an acid-binding agent a reactive ester of a basic alcohol of the formula HO-Y-Am III.
Sodium amide, sodium hydride, lithium amide, potassium amide, sodium, lithium or potassium are particularly suitable as acid-binding agents. The halides are particularly suitable as reactive esters of basic alcohols of the formula III. The following may be mentioned in detail: 1-methyl-3-chloropiperidine,
1-methyl-4-chloropiperidine,
1-methyl-pyrrolidyl- (2) -methyl chloride,
1-methyl-piperidyl- (2) -methylchloride,
1-methyl-piperidyl- (3) -methylchloride,
1-methyl-piperidyl- (4) -methylchloride, [l-methyl-piperidyl- (2)] -ethyl chloride and the corresponding bromides.
Suitable starting materials of the formula II are, for example, iminodibenzyl and imino stilbene and mono- and disubstitution products thereof, such as
3-ethyl-iminodibenzyl,
3-ethyl-iminostilbene,
3, 7-dimethyl-iminodibenzyl,
2, 8-dimethyl-iminodibenzyl,
3, 7-dichloro-iminodibenzyl and
3, 7-dichloro-iminostilbene.
By addition of halides or sulfates of aliphatic or araliphatic alcohols, e.g. B. of methyl iodide, dimethyl sulfate, ethyl bromide, ethyl iodide or benzyl chloride, arise from the tertiary amines of the formula I in the usual way monoquateric ammonium compounds, the tertiary amino group in the remainder Am reacting.
With inorganic or organic acids, such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulphonic acid, sithanesulphonic acid, ethane disulphonic acid, acetic acid, succinic acid, fumaric acid, maleic acid, malic acid, tartaric acid, citric acid, benzoic acid and phthalic acid form the tertiary bases, some of which are water-soluble are.
In the examples below, parts mean parts by weight; these relate to parts by volume as g to cm3. The temperatures are given in degrees Celsius.
example 1
19.5 parts of iminodibenzyl are dissolved in 125 parts by volume of o-xylene and mixed with 3.9 parts of finely powdered sodium amide. The resulting suspension is heated to 100 while stirring and passing in nitrogen until no more ammonia escapes. The contents of the flask are then cooled to 50 and a solution of 13.4 parts of 1-methyl-3-chloropiperidine in 60 parts by volume of o-xylene is added dropwise at this temperature. The suspension is then stirred for two hours at 100 and then refluxed for 14 hours. The reaction mixture, cooled to 0, is treated dropwise with water and stirred well for 2 hours. The two phases are now separated and the organic phase is extracted with 1N hydrochloric acid.
The acidic aqueous extract is made alkaline and extracted with ether, the ether is evaporated and the remaining oil is fractionated in a high vacuum. 5- [1'-Methyl-piperidyl- (3 ')] - iminodibenzyl of boiling point 165-167 is obtained at 0.02 mm pressure.
In an analogous manner one obtains: 5- [1'-methyl-piperidyl- (4)] - iminodibenzyl of bp 002 151-1546; 5- [1'-methyl-piperidyl- (3 ') -methyl] -iminodibenzyl of bp ool 157-160;
5- [ss- {1'-methyl-piperidyl- (2 ')} - ethyl] -inino-dibenzyl of bp 0003 178-181 and 5- [1'-methyl-pyrrolidyl- (2') - methyl] - iminodibenzyl from Kp. o, ol 145-147.
Example 2
19.5 parts of iminodibenzyl are dissolved in 100 parts by volume of benzene. Nitrogen is passed into the solution and 3.9 parts of sodium amide are introduced. The contents of the flask are then heated to 80 until no more ammonia escapes, and then cooled to 45. A solution of 14.8 parts of 1-methyl-piperidyl- (2) -methylchloride in 200 parts by volume of benzene is added dropwise to the resulting suspension in one and a half hours. The reaction mixture is then stirred for 12 hours at 45 and finally for a further two hours Boiled under reflux. The mixture, cooled rapidly to 5, is mixed with water, stirred for two hours and the two phases are separated. The benzene part is extracted with 1N hydrochloric acid.
The acidic aqueous extract is made mimosa-alkaline with sodium hydroxide solution and extracted with ether. After the ethereal solution has been dried with potassium carbonate, the ether is evaporated off and the residue is fractionated in a high vacuum, the 5- [1'-methyl-piperidyl- (2 ') -methyl] -imino-dibenzyl under 0.02 mm pressure at 165 -167 passes over. 5- [1'-methyl piperidyl- (4R) -methyl] -iminodibenzyl of boiling point 0.02172 to 174 is obtained in an analogous manner.
Example 3
19.3 parts of iminostilbene are dissolved in 500 parts by volume of benzene at 50-60. A solution of 14.8 parts of N-methylpiperidyl-4-methyl chloride in 400 parts by volume of benzene and a suspension of 4.0 parts of sodium amide in 12 parts by volume of toluene are added dropwise to this solution, while stirring in nitrogen. The suspension obtained is heated to 45 for a further 7 hours and then refluxed for 14 hours. After cooling with ice, 400 parts of water are added to the reaction mixture at 0-5.
The two phases are separated and the alkaline aqueous part is shaken well with ether. The ether solution is combined with the benzene phase and both extracted with 1 n hydrochloric acid. The hydrochloric acid extract is then made alkaline with sodium hydroxide solution and extracted with ether. The ether solution is dried with sodium carbonate and the ether is then evaporated. The crude oil that remains is distilled in a high vacuum, giving 5- [1'-methyl-piperidyl- (4 ') -methyl] -iminostilbene with a bp.
5- [1'-methyl-piperidyl- (2 ') -methyl] -iminostilbene with a boiling point of 0.05 169 to 172 is obtained in an analogous manner.
Example 4
19.3 parts of iminostilbene are dissolved in 600 parts by volume of xylene at 50-60. 16.2 parts of cJ- [1-methyl-piperidyl- (2)] ethyl chloride, dissolved in 400 parts by volume of xylene, are added dropwise to this solution. A suspension of 4.0 parts of sodium amide in 12 parts by volume of toluene is then added to the reaction mixture, the whole is stirred for 7 hours at 55 and finally refluxed for 14 hours. It is then cooled to 0 with ice and worked up analogously to the preceding examples, with the 5- [ss-w 1'-methyl-piperidyl- (2 ')} -ethyl] -iminostilbene of bp 170-172} under Receives 0.004mm print.
Claims (1)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6210558A CH367831A (en) | 1958-07-23 | 1958-07-23 | Process for the production of new basic substituted azepine derivatives |
| ES0250985A ES250985A1 (en) | 1958-07-23 | 1959-07-22 | Procedure for the preparation of new derivatives of azepine, basically replaced (Machine-translation by Google Translate, not legally binding) |
| ES0250986A ES250986A1 (en) | 1958-07-23 | 1959-07-22 | Procedure for the preparation of new derivatives of azepine, basically substituted (Machine-translation by Google Translate, not legally binding) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6210558A CH367831A (en) | 1958-07-23 | 1958-07-23 | Process for the production of new basic substituted azepine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH367831A true CH367831A (en) | 1963-03-15 |
Family
ID=4524088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6210558A CH367831A (en) | 1958-07-23 | 1958-07-23 | Process for the production of new basic substituted azepine derivatives |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH367831A (en) |
| ES (2) | ES250985A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2052991A1 (en) * | 1969-06-20 | 1971-04-16 | Sogeras | N-(dibenzo (bf) azepines quinuclidines |
-
1958
- 1958-07-23 CH CH6210558A patent/CH367831A/en unknown
-
1959
- 1959-07-22 ES ES0250985A patent/ES250985A1/en not_active Expired
- 1959-07-22 ES ES0250986A patent/ES250986A1/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2052991A1 (en) * | 1969-06-20 | 1971-04-16 | Sogeras | N-(dibenzo (bf) azepines quinuclidines |
Also Published As
| Publication number | Publication date |
|---|---|
| ES250986A1 (en) | 1960-01-16 |
| ES250985A1 (en) | 1960-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2803651C2 (en) | ||
| DE2851028A1 (en) | NEW INDOLO SQUARE CLAMP ON 2.3-A SQUARE CLAMP ON CHINOLICIDINE, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION CONTAINING IT | |
| DE949105C (en) | Process for the production of new, fungicidal and protozoocidal aromatic aminoketones and their salts | |
| DE934651C (en) | Process for the preparation of tetrasubstituted diaminoalkanes | |
| CH367831A (en) | Process for the production of new basic substituted azepine derivatives | |
| CH438352A (en) | Process for the preparation of diphenylalkylamines | |
| DE68912887T2 (en) | Thiophene-2-carboxamide derivatives and their use as pharmaceutical agents. | |
| DE1620128A1 (en) | Process for the preparation of new organic amides | |
| AT236389B (en) | Process for the preparation of new N-substituted heterocyclic compounds | |
| AT217045B (en) | Process for the preparation of new monoalkylated or monohalogenated N-derivatives of 10,11-dihydro-5H-dibenzo [b, f] azepines and 5H-dibenzo [b, f] azepines | |
| AT220623B (en) | Process for the preparation of new N-heterocyclic compounds | |
| AT212326B (en) | Process for the production of new, basic substituted azepine derivatives | |
| AT222130B (en) | Process for the preparation of new N-heterocyclic compounds | |
| AT204041B (en) | Process for the production of new phenthiazine derivatives | |
| AT233579B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT233581B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT233019B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT228218B (en) | Process for the preparation of new thioxanthene compounds | |
| AT201603B (en) | Process for the preparation of the new piperazo [c] pyridazine compounds | |
| AT219613B (en) | Process for the preparation of new N-heterocyclic compounds and their salts | |
| AT360991B (en) | METHOD FOR PRODUCING NEW 1-ALKYL-4-PHENYLPIPERIDINE DERIVATIVES AND THEIR SALTS AND OPTICALLY ACTIVE COMPOUNDS | |
| AT219036B (en) | Process for the preparation of new 3-substituted 1-benzylindanes and their salts | |
| AT225712B (en) | Process for the preparation of a new N-heterocyclic compound | |
| AT233014B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT208869B (en) | Process for the production of new N-substituted azepines |